Log in

NASDAQ:CBMGCellular Biomedicine Group SEC Filings & 10K Form

$13.77
-0.03 (-0.22 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$13.37
Now: $13.77
$13.81
50-Day Range
$13.35
MA: $14.64
$16.00
52-Week Range
$10.98
Now: $13.77
$18.99
Volume62,056 shs
Average Volume86,751 shs
Market Capitalization$267.00 million
P/E RatioN/A
Dividend YieldN/A
Beta1.64

SEC Filings

Cellular Biomedicine Group (NASDAQ:CBMG) SEC Filings

DateFilerForm TypeView
05/08/2020
5:07 AM
Cellular Biomedicine Group (Filer)
Form DEFR14A
04/29/2020
4:19 PM
Cellular Biomedicine Group (Filer)
Form DEFA14A
04/29/2020
4:19 PM
Cellular Biomedicine Group (Filer)
Form DEF 14A
04/01/2020
8:39 AM
Cellular Biomedicine Group (Subject)
Sailing Capital Overseas Investments Fund, LP (Filed by)
Form SC 13D/A
04/01/2020
8:37 AM
Cellular Biomedicine Group (Subject)
TF Venture Capital Management Co., Ltd. (Filed by)
Form SC 13D/A
04/01/2020
8:33 AM
Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
Form SC 13D/A
03/31/2020
9:16 AM
Cellular Biomedicine Group (Subject)
Dangdai International Group Co. Ltd (Filed by)
Form SC 13D/A
02/24/2020
12:50 PM
Cellular Biomedicine Group (Subject)
Dangdai International Group Co. Ltd (Filed by)
Form SC 13D/A
02/24/2020
7:00 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
3:05 PM
Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
Form SC 13D/A
02/13/2020
4:23 PM
Cellular Biomedicine Group (Issuer)
Chan Andrew K (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/13/2020
4:20 PM
Cellular Biomedicine Group (Issuer)
Liu Tony (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2020
7:07 PM
Cellular Biomedicine Group (Issuer)
Chiang Chen Hsiu-Lien (Reporting)
TF Venture Capital Management Co., Ltd. (Reporting)
Winsor Capital Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/03/2020
9:19 AM
Cellular Biomedicine Group (Subject)
TF Venture Capital Management Co., Ltd. (Filed by)
Form SC 13D
01/30/2020
8:18 AM
Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
Form SC 13D/A
01/30/2020
8:17 AM
Cellular Biomedicine Group (Subject)
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
Form SC 13D/A
01/29/2020
4:00 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2019
7:30 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
5:02 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
8:56 PM
Cellular Biomedicine Group (Issuer)
Zhang Li Helen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2019
8:53 PM
Cellular Biomedicine Group (Issuer)
Dai Chengxiang (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2019
8:50 PM
Cellular Biomedicine Group (Issuer)
HILLHOUSE CAPITAL ADVISORS, LTD. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/18/2019
8:56 PM
Cellular Biomedicine Group (Issuer)
Mission Right Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/18/2019
10:55 AM
Cellular Biomedicine Group (Subject)
Dangdal International Group Co. Ltd (Filed by)
Form SC 13D/A
11/13/2019
9:07 AM
Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
Form SC 13D
11/12/2019
8:59 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
7:00 AM
Cellular Biomedicine Group (Subject)
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
Form SC 13D
11/08/2019
6:27 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:25 PM
Cellular Biomedicine Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2019
3:10 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
3:12 PM
Cellular Biomedicine Group (Issuer)
Schafer Edward T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
3:11 PM
Cellular Biomedicine Group (Issuer)
Schafer Edward T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/03/2019
7:30 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
3:15 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
4:01 PM
Cellular Biomedicine Group (Filer)
Form CT ORDER
09/12/2019
6:49 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
2:24 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2019
3:10 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:03 PM
Cellular Biomedicine Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2019
8:07 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
11:15 PM
Cellular Biomedicine Group (Filer)
Form EFFECT
07/05/2019
3:12 PM
Cellular Biomedicine Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2019
4:09 PM
Cellular Biomedicine Group (Filer)
Form 424B3
07/01/2019
4:25 PM
Cellular Biomedicine Group (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/17/2019
7:23 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2019
4:20 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
4:01 PM
Cellular Biomedicine Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2019
8:27 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
8:44 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2019
8:24 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2019
10:33 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2019
8:31 PM
Cellular Biomedicine Group (Filer)
Form 424B5
03/22/2019
4:29 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
3:20 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
3:11 PM
Cellular Biomedicine Group (Filer)
Form 424B5
03/15/2019
4:13 PM
Cellular Biomedicine Group (Filer)
Form DEFA14A
03/15/2019
4:11 PM
Cellular Biomedicine Group (Filer)
Form DEF 14A
03/01/2019
10:05 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
4:01 PM
Cellular Biomedicine Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
8:53 PM
Cellular Biomedicine Group (Issuer)
Chan Andrew K (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2019
8:50 PM
Cellular Biomedicine Group (Issuer)
Liu Tony (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2019
8:48 PM
Cellular Biomedicine Group (Issuer)
Yao Yihong (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/25/2019
3:45 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2019
5:30 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2019
7:00 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2018
3:11 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
1:10 PM
Cellular Biomedicine Group (Subject)
Dangdal International Group Co. Ltd (Filed by)
Form SC 13D/A
11/06/2018
5:26 AM
Cellular Biomedicine Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2018
7:07 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2018
8:16 AM
Cellular Biomedicine Group (Filer)
Form 424B3
10/22/2018
11:15 PM
Cellular Biomedicine Group (Filer)
Form EFFECT
10/18/2018
3:13 PM
Cellular Biomedicine Group (Filer)
Form CT ORDER
10/18/2018
3:06 PM
Cellular Biomedicine Group (Filer)
Form CT ORDER
10/10/2018
6:11 PM
Cellular Biomedicine Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/10/2018
7:30 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
4:27 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
7:00 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2018
3:33 PM
Cellular Biomedicine Group (Subject)
NOVARTIS PHARMA AG (Filed by)
Form SC 13G
09/27/2018
6:45 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2018
8:00 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2018
3:10 PM
Cellular Biomedicine Group (Issuer)
Hau Bosun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2018
3:10 PM
Au Chun Kwok Alan (Reporting)
Cellular Biomedicine Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2018
3:10 PM
Cellular Biomedicine Group (Issuer)
Patel Nadir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2018
3:10 PM
Belmont Terry (Reporting)
Cellular Biomedicine Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2018
3:10 PM
Cellular Biomedicine Group (Issuer)
Ji Gang Jacky (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2018
3:10 PM
Cellular Biomedicine Group (Issuer)
Zhou Hansheng (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2018
4:27 PM
Cellular Biomedicine Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2018
8:11 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2018
7:42 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2018
7:33 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2018
3:05 PM
Cellular Biomedicine Group (Issuer)
Liu Wen Tao (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2018
3:11 PM
Cellular Biomedicine Group (Filer)
Form 424B3
04/09/2018
11:15 PM
Cellular Biomedicine Group (Filer)
Form EFFECT
04/02/2018
3:17 PM
Cellular Biomedicine Group (Filer)
Form S-3/A
03/16/2018
8:56 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2018
11:40 AM
Cellular Biomedicine Group (Issuer)
Hau Bosun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2018
4:29 PM
Cellular Biomedicine Group (Filer)
Form DEFA14A
03/12/2018
4:15 PM
Cellular Biomedicine Group (Filer)
Form DEF 14A
03/06/2018
12:31 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2018
3:51 PM
Cellular Biomedicine Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.